Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Spatial transcriptomics data of RM9-hSTEAP1 tumor tissues treated with CAR-T cells

ABSTRACT: Spatial transcriptomics data of RM9-hSTEAP1 tumor tissues treated with CAR-T cells

PROVIDER: PRJNA1282021 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR34173862_1.fastq.gz	Fastqsanger.gz
	SRR34173862_2.fastq.gz	Fastqsanger.gz
	SRR34173863_1.fastq.gz	Fastqsanger.gz
	SRR34173863_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 37

Similar Datasets

Spatial transcriptomics of colorectal cancer tissues

Project description:Spatial transcriptomics of colorectal cancer tissues

| PRJNA1111415 | ENA

Spatial transcriptomics data of RM9-hSTEAP1 tumor tissues treated with CAR-T cells

Project description:Immunosuppressive microenvironments, the lack of immune infiltration, and antigen heterogeneity pose challenges for chimeric antigen receptor (CAR)-T cell therapies applied to solid tumors. Previously, CAR-T cells were armored with immunostimulatory molecules, such as interleukin-12 (IL-12), to overcome this issue, but faced high toxicity. Here, we show that collagen-binding domain-fused IL-12 (CBD-IL-12) secreted from CAR-T cells to target human six transmembrane epithelial antigen of the prostate 1 (STEAP1) is retained within murine prostate tumors. This leads to high intratumoral interferon-γ levels, without hepatotoxicity and infiltration of T cells into non-target organs compared with unmodified IL-12. Both innate and adaptive immune compartments are activated and recognize diverse tumor antigens after CBD-IL-12-armored CAR-T cell treatment. Combination of CBD-IL-12-armored CAR-T cells and immune checkpoint inhibitors eradicated large tumors in an established prostate cancer mouse model. Additionally, human CBD-IL-12-armored CAR-T cells showed potent anti-tumor efficacy in an 22Rv1 xenograft while reducing circulating IL-12 levels compared with unmodified IL-12-armored CAR-T cells. CBD-fusion to potent payloads of CAR-T therapy may remove obstacles to their clinical translation towards elimination of solid tumors.

2025-06-25 | GSE300750 | GEO

CAR-T-drug conjugate against solid tumor [Spatial Transcriptomics]

Project description:CAR-T-drug conjugate against solid tumor [Spatial Transcriptomics]

| PRJNA1478025 | ENA

Single-Cell and Spatial Transcriptomics Analysis of Human Adrenal Aging (spatial transcriptomics)

Project description:These data were used in the spatial transcriptomics analysis of the article titled \\"Single-Cell and Spatial Transcriptomics Analysis of Human Adrenal Aging\\".

2024-04-22 | E-MTAB-13991 | biostudies-arrayexpress

Subcellular mRNA localization patterns across tissues resolved with spatial transcriptomics

Project description:Subcellular RNA localization, including nuclear retention and apical-basal compartmentalization in polarized epithelia plays a central role in post-transcriptional regulation. However, methods for high-throughput mapping of mRNA localization within intact tissue sections remain limited. Here, we apply high-resolution spatial transcriptomics to systematically resolve intracellular mRNA localization across diverse mammalian tissues. We introduce a computational approach that leverages image-derived features to extract subcellular information from spatial data and quantifies transcript localization patterns. Using this framework, we map apical-basal mRNA localization and nuclear retention in gastrointestinal epithelia and in liver hepatocytes. Our analyses reveal conserved and tissue-specific localization signatures that can be readily obtained from standard high-definition spatial transcriptomics experiments. This approach broadens the scope of spatial transcriptomics by enabling routine investigation of intracellular RNA distributions in both healthy and diseased tissues.

2026-04-06 | GSE327129 | GEO

Mapping immune development across tissues in the human fetus - 10X spatial transcriptomics

Project description:To study the spatial localisations of the cell populations in an early haematopoietic tissue and lymphoid organs critical for T and B cell development, we profiled fetal liver, thymus and spleen from 3 donors at 18 PCW with sequencing-based spatial transcriptomics (10x Genomics Visium).

2022-05-12 | E-MTAB-11341 | biostudies-arrayexpress

Spatial transcriptomics of mouse tissues

Project description:Spatial transcriptomics of mouse tissues

2026-04-02 | OEX00032614 | NODE

CAR-T-drug conjugate against solid tumor [Spatial Transcriptomics]

Project description:Chimeric antigen receptor (CAR)-T cell therapy has been clinically successful in hematologic malignancies but faces challenges in solid tumors, including limited infiltration, immunosuppressive microenvironments and antigen heterogeneity. While combining CAR-T cell therapy with chemotherapy can enhance antitumor activity, this often leads to substantial systemic toxicity. Here we show that CAR-T-drug conjugate (CAR-T-D-C), generated through click chemistry-mediated conjugation of cytotoxic payloads to antigen-specific CAR-T cells, enable localized drug delivery while preserving CAR-T cell function. CAR-T-D-Cs incorporating different CAR-T cell binders exhibit robust antitumor activity across multiple human xenografts and syngeneic tumor models. Spatial transcriptomic analyses reveal enhanced intratumoral CAR-T infiltration and activation following CAR-T-D-C treatment . Compared with conventional CAR-T therapy, CAR-T-D-C enhances immune cell infiltration, augments effector functions, promotes antigen spreading and amplifies systemic anti-tumor immunity. CAR-T-D-C represents a versatile therapeutic platform that combines the specificity of cellular immunotherapy with the potency of small-molecule therapeutics for treatment of solid tumors.

2026-06-26 | GSE335372 | GEO

Spatial transcriptomics of squamous cell carcinoma from different tissues

Project description:Spatial transcriptomics of squamous cell carcinoma from different tissues

| PRJNA1429337 | ENA

Spatial transcriptomics of 12 tumor tissues from colorectal cancer

Project description:Spatial transcriptomics of 12 tumor tissues from colorectal cancer

| PRJNA1191506 | ENA